Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-077226
Filing Date
2025-05-23
Accepted
2025-05-23 18:48:02
Documents
1
Period of Report
2025-05-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3757
  Complete submission text file 0000950170-25-077226.txt   5180
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RANI THERAPEUTICS HOLDINGS, INC. 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address
Hashim Mir (Reporting) CIK: 0001875891 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40672 | Film No.: 25983798